Sugi Predict

Sugi Predict / Compounds / SCHEMBL342537

SCHEMBL342537

SCHEMBL342537

Nc1cc(S(=O)(=O)O)ccc1S(=O)(=O)O.[Na]

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.64
▸ HSD17B10 Q99714 4/20 0.64
▸ CASP6 P55212 3/20 0.61
▸ CYP2C9 P11712 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ NT5E P21589 3/20 0.52
▸ TSHR P16473 2/20 0.52
▸ TDP1 Q9NUW8 1/20 0.50
▸ GAA P10253 3/20 0.48
▸ KDM4E B2RXH2 3/20 0.48
▸ MAPT P10636 2/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ PKM P14618 1/20 0.48
▸ RAB9A P51151 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ CA2 P00918 4/20 0.47
▸ NSD2 O96028 2/20 0.46
▸ PLCG1 P19174 1/20 0.46
▸ DNMT1 P26358 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29702840 1.00 ALDH1A1 (0.64) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL149375 1.00 ALDH1A1 (0.64) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL342535 0.98 ALDH1A1 (0.62) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL28780394 0.98 ALDH1A1 (0.62) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL15194640 0.98 ALDH1A1 (0.62) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL15194427 0.98 ALDH1A1 (0.62) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
Benzene SCHEMBL11045134 0.96 ALDH1A1 (0.60) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
Nitrogen SCHEMBL222779 0.96 ALDH1A1 (0.60) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL10924335 0.92 ALDH1A1 (0.56) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19
SCHEMBL11116200 0.92 ALDH1A1 (0.56) ALDH1A1HSD17B10CASP6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117986929-A Room-temperature phosphorescent ink based on bio-based molecules-aromatic sulfonic acid or salts thereof, and preparation method and application thereof 仲恺农业工程学院 2024-05-07 — — CN claimed
CN-115926860-A Coal water slurry additive prepared by using industrial byproduct and preparation method thereof 河北建新化工股份有限公司 2023-04-07 — — CN claimed
CN-113593931-B Preparation method of supercapacitor electrode material NiCoMn-LDH/functionalized graphene 燕山大学 2022-04-01 — — CN claimed
CN-113593931-A Preparation method of supercapacitor electrode material NiCoMn-LDH/functionalized graphene 燕山大学 2021-11-02 — — CN claimed
CN-109651839-B Preparation method of orange reactive printing dye 浙江劲光实业股份有限公司 2020-09-01 — — CN claimed
CN-1169710-C Process for preparing hydrogen sulfide 唐培� 2004-10-06 — — CN claimed
CN-1203886-A Method for producing hydrogen sulfide TANG PEISI (CN) 1999-01-06 — — CN claimed
CN-112724349-B Polymer and use thereof 立邦涂料（中国）有限公司 2024-07-05 — — CN disclosed
CN-117986929-A Room-temperature phosphorescent ink based on bio-based molecules-aromatic sulfonic acid or salts thereof, and preparation method and application thereof 仲恺农业工程学院 2024-05-07 — — CN disclosed
US-20240000084-A1 ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD ACENET INC. (JP) 2024-01-04 — — US disclosed
US-20230263710-A1 ORAL CARE AGENT OSAKA UNIVERSITY (JP) 2023-08-24 — — US disclosed
EP-4230042-A1 ANTIPATHOGENIC DRUG, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN PROCESSING DEVICE, METHOD FOR PRODUCING ANTIPATHOGENIC DRUG, ANTIBACTERIAL METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN PROCESSING METHOD Acenet Inc. (JP) 2023-08-23 — — EP disclosed
US-20230181628-A1 EPITHELIAL CANCER THERAPEUTIC AGENT OSAKA UNIVERSITY (JP) 2023-06-15 — — US disclosed
WO-2006059407-A9 METHOD OF GAS RESISTANCE TEST FOR IMAGE AND INK SET CANON KK (JP) 2006-09-14 — — WO disclosed
EP-1693422-A1 TRISAZO COMPOUND, INK COMPOSITION, AND COLORED OBJECT Nippon Kayaku Kabushiki Kaisha (JP) 2006-08-23 — — EP disclosed
WO-2006059407-A1 METHOD OF GAS RESISTANCE TEST FOR IMAGE AND INK SET CANON KABUSHIKI KAISHA (JP) 2006-06-08 — — WO disclosed
CN-1169710-C Process for preparing hydrogen sulfide 唐培� 2004-10-06 — — CN disclosed
CN-1342600-A Process for preparing hydrogen sulfide TANG PEIKUN (CN) 2002-04-03 — — CN disclosed
CN-1064023-C Method for producing hydrogen sulfide TANG PEISI (CN) 2001-04-04 — — CN disclosed
CN-1203886-A Method for producing hydrogen sulfide TANG PEISI (CN) 1999-01-06 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263710-A1 ORAL CARE AGENT TAS2R39, TAS2R40, TAS2R45 ALDH1A1 2248/4885HSD17B10 4035/4885CASP6 4185/4885
US-20230181628-A1 EPITHELIAL CANCER THERAPEUTIC AGENT EPCAM, EGFR, MUC1 ALDH1A1 245/4885HSD17B10 2467/4885CASP6 1197/4885
US-20240000084-A1 ANTIPATHOGENIC AGENT, ANTIBACTERIAL AGENT, ANTIVIRAL AGENT, PATHOGEN DISPOSAL DEVICE, ANTIPATHOGENIC AGENT PRODUCTION METHOD, ANTIBACTERIAL TREATMENT METHOD, VIRUS INACTIVATION METHOD, AND PATHOGEN DISPOSAL METHOD EIF2AK2, HAO2, ZC3HAV1 ALDH1A1 1641/4885HSD17B10 2328/4885CASP6 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.